Phocas Financial »

Crinetics Pharmaceuticals In shares owned by Phocas Financial

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Phocas Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2M 54k 41.65

More positions owned by Phocas Financial

Adtalem Global Ed (ATGE)
Primoris Services (PRIM)
Wintrust Financial Corporation (WTFC)
Nexstar Media Group Common Stock (NXST)
TTM Technologies (TTMI)
SkyWest (SKYW)
Stonex Group (SNEX)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Ameris Ban (ABCB)
Meta Financial (CASH)
Columbia Banking System (COLB)
Sanmina (SANM)
Preferred Bk Los Angeles Ca Com New (PFBC)
Aar (AIR)
First Horizon National Corporation (FHN)

View all positions for Phocas Financial

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Driehaus Capital Management
Farallon Capital Management
EcoR1 Capital
Henderson Group
Paradigm Biocapital Advisors
Geode Capital Management
State Street Corporation
Jennison Associates
Point72 Asset Management
Siren
Novo A/S

View all funds holding Crinetics Pharmaceuticals In